Emerging Understandings Regarding the Impact of BDNF on Peripheral Health and Disease

Tunn Oesswone^*
*Correspondence: Tunn Oesswone, Department of Neurosurgery, Kaohsiung Medical University, Kaohsiung 807, Taiwan, Email:

Introduction

Brain-Derived Neurotrophic Factor (BDNF) has long been hailed as a pivotal player in neurobiology, renowned for its role in neuronal survival, growth and synaptic plasticity within the Central Nervous System (CNS). However, recent scientific inquiries have begun to unravel a previously overlooked facet of BDNF-its profound influence on peripheral tissues and organ systems. This emerging understanding has sparked a paradigm shift, expanding the scope of BDNF's impact beyond the confines of the brain and into the realm of peripheral health and disease. The recognition of BDNF's presence and activity outside the CNS signifies a significant departure from conventional wisdom [1]. Historically, BDNF was primarily viewed through the lens of neurobiology, with its functions confined to neuronal development, synaptic plasticity and cognitive processes. However, advancements in research techniques and methodologies have revealed that BDNF is synthesized and released by various peripheral tissues, where it exerts diverse effects on cellular functions and physiological processes.

Understanding the molecular mechanisms through which BDNF operates in peripheral tissues is fundamental to elucidating its broader physiological significance. BDNF exerts its effects through interaction with specific receptors, such as Tropomyosin receptor kinase B (TrkB) and p75 Neurotrophin Receptor (p75NTR), triggering downstream signaling pathways that modulate cellular functions. Moreover, the multifaceted nature of BDNF's actions in the periphery underscores its potential as a key regulator of health and disease beyond neurological disorders. This paper aims to explore and synthesize the emerging understandings regarding the impact of BDNF on peripheral health and disease. Through a comprehensive review of current literature, we will delve into the molecular mechanisms underlying BDNF's actions in peripheral tissues, its implications for various physiological processes and its relevance to the pathogenesis and management of peripheral disorders. By shedding light on this novel dimension of BDNF biology, we hope to foster a deeper appreciation of its multifaceted roles and potential therapeutic implications in peripheral health [2].

Description

The emerging recognition of BDNF's influence on peripheral health and disease represents a paradigm shift in our understanding of neurotrophin biology. While BDNF's role in the CNS has been extensively studied and well-established, its activities in peripheral tissues have only recently come into focus. One of the key revelations is that BDNF is not confined to the brain but is synthesized and released by a wide range of peripheral tissues, including adipose tissue, skeletal muscle, liver, heart and immune cells. In peripheral tissues, BDNF exerts diverse effects on cellular functions and physiological processes through activation of its receptors, primarily TrkB and p75NTR. These effects encompass a broad spectrum of functions, including regulation of metabolism, cardiovascular function, immune responses, gastrointestinal motility, musculoskeletal health and neuroendocrine regulation. For instance, BDNF has been implicated in the regulation of energy balance, glucose homeostasis and adipose tissue metabolism, with dysregulation of BDNF signaling contributing to metabolic disorders such as obesity and diabetes [3].

Furthermore, BDNF plays a crucial role in cardiovascular health by influencing endothelial function, vascular remodeling and angiogenesis. Its dysregulation has been implicated in various cardiovascular diseases, including hypertension, atherosclerosis and heart failure. Similarly, BDNF's immunomodulatory properties have implications for inflammatory and autoimmune diseases, as well as wound healing and tissue repair processes. Moreover, BDNF exerts significant effects on gastrointestinal function, including modulation of gastrointestinal motility, mucosal integrity and communication within the gut-brain axis. Dysregulation of BDNF signaling has been implicated in gastrointestinal disorders such as irritable bowel syndrome and inflammatory bowel disease. Additionally, BDNF influences musculoskeletal health by regulating muscle function, regeneration and bone metabolism, with implications for conditions like sarcopenia and osteoporosis [4].

Furthermore, BDNF interacts with neuroendocrine systems, including the Hypothalamic-Pituitary-Adrenal (HPA) axis, to regulate stress responses, reproductive functions and hormone secretion. Dysregulation of BDNF signaling in these pathways has been implicated in various neuroendocrine disorders. Overall, the burgeoning body of evidence highlighting BDNF's multifaceted roles in peripheral tissues underscores its significance as a key regulator of physiological homeostasis and pathophysiological processes. Understanding the intricate mechanisms through which BDNF operates in peripheral organs holds immense promise for unraveling the etiology of peripheral disorders and developing novel therapeutic strategies targeting BDNF pathways [5].

Conclusion

In conclusion, the emerging understandings regarding the impact of BDNF on peripheral health and disease represent a paradigm shift in neurotrophin biology, expanding our perception of BDNF beyond its traditional roles in the CNS. The recognition of BDNF's presence and activity in peripheral tissues underscores its multifaceted roles as a key regulator of physiological processes beyond neuronal function. Through interaction with specific receptors and activation of downstream signaling pathways, BDNF exerts diverse effects on peripheral tissues, influencing metabolism, cardiovascular function, immune responses, gastrointestinal health, musculoskeletal integrity and neuroendocrine regulation. Dysregulation of BDNF signaling has been implicated in a wide array of peripheral disorders, ranging from metabolic diseases and cardiovascular disorders to gastrointestinal, musculoskeletal and neuroendocrine disorders. The elucidation of BDNF's actions in peripheral tissues holds significant implications for both basic research and clinical practice. By deepening our understanding of the molecular mechanisms underlying BDNF's peripheral effects, we can gain insights into the pathophysiology of various peripheral disorders and identify novel therapeutic targets for intervention. Moreover, harnessing the therapeutic potential of BDNF modulation may pave the way for innovative treatment strategies aimed at restoring physiological homeostasis and improving clinical outcomes in diverse disease contexts.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Levi-Montalcini, Rita. "Developmental neurobiology and the natural history of nerve growth factor." Annu Rev Neurosci 5 (1982): 341-362.

Google Scholar, Crossref, Indexed at

2. Shelton, David L. and Louis F. Reichardt. "Studies on the expression of the beta Nerve Growth Factor (NGF) gene in the central nervous system: Level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons." Proc Natl Acad Sci 83 (1986): 2714-2718.

Google Scholar, Crossref, Indexed at

3. Leibrock, Joachim, Friedrich Lottspeich, Andreas Hohn and Magdalena Hofer, et al. "Molecular cloning and expression of brain-derived neurotrophic factor." Nature 341 (1989): 149-152.

Google Scholar, Crossref, Indexed at

4. Bibel, Miriam and Yves-Alain Barde. "Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system." Genes Dev 14 (2000): 2919-2937.

Google Scholar, Crossref, Indexed at

5. Chao, Moses V. "Neurotrophins and their receptors: A convergence point for many signalling pathways." Nat Rev Neurosci 4 (2003): 299-309.

Google Scholar, Crossref, Indexed at